Search research articles
Contact Us
Filters
Showing results (81-90 of 127) with videos related to
Page
of 13
Sort By:
Journal of Pharmaceutical Sciences
|
April 25, 2017
Clinical Drug-Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access
Dinko Rekić, Kellie S Reynolds, Ping Zhao, et al.
American Heart Journal
|
March 3, 2009
The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE)
Vera Bittner, B Delia Johnson, Issam Zineh, et al.
Pharmacotherapy
|
March 1, 2006
Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors
Issam Zineh, Xiaoping Luo, Gregory J Welder, et al.
Journal of Pharmaceutical Sciences
|
November 6, 2018
Role of Modeling and Simulation in the Development of Novel and Biosimilar Therapeutic Proteins
Yow-Ming C Wang, Yaning Wang, Sarah J Schrieber, et al.
Pharmacogenetics and Genomics
|
May 13, 2011
Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study
Elvin Tyrone Price, Michael A Pacanowski, Michael A Martin, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 26, 2019
Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and Simulation
Colleen Kuemmel, Yuching Yang, Xinyuan Zhang, et al.
Nature Reviews. Drug Discovery
|
November 1, 2007
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Russell A Wilke, Debbie W Lin, Dan M Roden, et al.
Plos One
|
September 5, 2008
Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins
Issam Zineh, Amber L Beitelshees, Gregory J Welder, et al.
Nature Reviews. Drug Discovery
|
February 2, 2013
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective
Marc Maliepaard, Charity Nofziger, Marisa Papaluca, et al.
Clinical Pharmacology and Therapeutics
|
July 15, 2020
Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real-World Setting
Kimberly Maxfield, Lauren Milligan, Lingshan Wang, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 127) with videos related to
Sort By:
Page
of 13
Journal of Pharmaceutical Sciences
|
April 25, 2017
Clinical Drug-Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access
Dinko Rekić, Kellie S Reynolds, Ping Zhao, et al.
American Heart Journal
|
March 3, 2009
The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE)
Vera Bittner, B Delia Johnson, Issam Zineh, et al.
Pharmacotherapy
|
March 1, 2006
Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors
Issam Zineh, Xiaoping Luo, Gregory J Welder, et al.
Journal of Pharmaceutical Sciences
|
November 6, 2018
Role of Modeling and Simulation in the Development of Novel and Biosimilar Therapeutic Proteins
Yow-Ming C Wang, Yaning Wang, Sarah J Schrieber, et al.
Pharmacogenetics and Genomics
|
May 13, 2011
Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study
Elvin Tyrone Price, Michael A Pacanowski, Michael A Martin, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 26, 2019
Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and Simulation
Colleen Kuemmel, Yuching Yang, Xinyuan Zhang, et al.
Nature Reviews. Drug Discovery
|
November 1, 2007
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Russell A Wilke, Debbie W Lin, Dan M Roden, et al.
Plos One
|
September 5, 2008
Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins
Issam Zineh, Amber L Beitelshees, Gregory J Welder, et al.
Nature Reviews. Drug Discovery
|
February 2, 2013
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective
Marc Maliepaard, Charity Nofziger, Marisa Papaluca, et al.
Clinical Pharmacology and Therapeutics
|
July 15, 2020
Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real-World Setting
Kimberly Maxfield, Lauren Milligan, Lingshan Wang, et al.
Page
of 13